G protein coupled receptor dimerization: implications in modulating receptor function

Abstract Protein-protein interactions are involved in the regulation of a large number of biological processes. It is well established that a variety of cell surface receptors interact with each other to form dimers, and that this is essential for their activation. Although the existence of G protein coupled receptor dimers was predicted from early pharmacological and biochemical analysis, solid evidence supporting dimerization has come within the past few years following the cloning of G protein coupled receptor cDNAs. Using differential epitope tagging and selective immunoisolation of receptor complexes, dimerization of a number of G protein coupled receptors including members of the rhodopsin, secretin, and metabotropic glutamate receptor families have been reported. More recently fluorescence or bioluminescence resonance energy transfer techniques have been used to examine dimerization of these receptors in live cells. These studies have found that whereas in some cases there is an agonist induced increase in the level of dimers, in others there is a decrease or no change in dimer levels. Several recent studies have also reported the ability of related members of G protein coupled receptors to heterodimerize. These heterodimers exhibit distinct physical and functional properties. Examination of possible sites of interactions between receptors has implicated a role for extracellular, transmembrane and/or C-terminal region in dimerization. The functional consequences of dimerization, explored mainly using mutant receptors, have demonstrated a role in modulating agonist affinity, efficacy, and/or trafficking properties. Thus dimerization appears to be a universal phenomenon that provides an additional mechanism for modulation of receptor function as well as cross-talk between G protein coupled receptors.

[1]  L. Devi,et al.  Kappa opioid receptor endocytosis by dynorphin peptides. , 2000, DNA and cell biology.

[2]  T. Schwartz,et al.  Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.

[3]  Jonathan A Javitch,et al.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.

[4]  R. Lefkowitz,et al.  Beta-adrenergic receptors: evidence for negative cooperativity. , 1975, Biochemical and biophysical research communications.

[5]  A. Couvineau,et al.  Receptors for VIP, PACAP, Secretin, GRF, Glucagon, GLP‐1, and Other Members of Their New Family of G Protein‐Linked Receptors: Structure‐Function Relationship with Special Reference to the Human VIP‐1 Receptor a , 1996, Annals of the New York Academy of Sciences.

[6]  J. Shiloach,et al.  Expression, Purification, and Biochemical Characterization of the Amino-terminal Extracellular Domain of the Human Calcium Receptor* , 1999, The Journal of Biological Chemistry.

[7]  J. Venter,et al.  The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. , 1982, Biochemical and biophysical research communications.

[8]  F. Marshall,et al.  GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.

[9]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[10]  L. Kohn,et al.  Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wild-type receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. , 1992, Endocrinology.

[11]  L. Potter,et al.  Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors. , 1989, The Journal of pharmacology and experimental therapeutics.

[12]  H. W. Harris,et al.  Disulfide Bonds in the Extracellular Calcium-Polyvalent Cation-sensing Receptor Correlate with Dimer Formation and Its Response to Divalent Cations in Vitro * , 1998, The Journal of Biological Chemistry.

[13]  J. Holaday,et al.  Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites. , 1989, European journal of pharmacology.

[14]  K. Catt,et al.  Physicochemical characterization of photoaffinity-labeled angiotensin II receptors. , 1987, Molecular endocrinology.

[15]  S. Hirose,et al.  Ig-Hepta, a Novel Member of the G Protein-coupled Hepta-helical Receptor (GPCR) Family That Has Immunoglobulin-like Repeats in a Long N-terminal Extracellular Domain and Defines a New Subfamily of GPCRs* , 1999, The Journal of Biological Chemistry.

[16]  K. Catt,et al.  Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling. , 1980, The Journal of biological chemistry.

[17]  S. Meloche,et al.  Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa. , 1990, The Biochemical journal.

[18]  E I Canela,et al.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Engelman,et al.  Sequence specificity in the dimerization of transmembrane alpha-helices. , 1992, Biochemistry.

[20]  A. Golbraikh,et al.  A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments. , 1999, European journal of biochemistry.

[21]  Michel Bouvier,et al.  Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.

[22]  B. Hietel,et al.  Target size analysis of opioid receptors. No difference between receptor types, but discrimination between two receptor states. , 1986, European journal of biochemistry.

[23]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[24]  A. Scheer,et al.  Theoretical study of the electrostatically driven step of receptor‐G protein recognition , 1999, Proteins.

[25]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[26]  J. Garnier,et al.  Towards understanding the glycoprotein hormone receptors. , 1991, Biochimie.

[27]  R. Snyderman,et al.  Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. , 1994, The Journal of biological chemistry.

[28]  R. Lefkowitz,et al.  Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. , 1976, The Journal of biological chemistry.

[29]  A. Valencia,et al.  Correlated mutations contain information about protein-protein interaction. , 1997, Journal of molecular biology.

[30]  E. Brown,et al.  Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions. , 1996, Bailliere's clinical endocrinology and metabolism.

[31]  K. Fuxe,et al.  Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.

[32]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[33]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[34]  C. Reynolds,et al.  A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.

[35]  Christian Le Gouill,et al.  Selective Modulation of Wild Type Receptor Functions by Mutants of G-Protein-coupled Receptors* , 1999, The Journal of Biological Chemistry.

[36]  E. Brown,et al.  Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.

[37]  G. Demontis,et al.  G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.

[38]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[39]  J. Holaday,et al.  Morphine tolerance increases -noncompetative d binding sites? , 1986 .

[40]  E. Escher,et al.  Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. , 1983, Biochemistry.

[41]  I. Siemens,et al.  Solubilization and Partial Characterization of Angiotensin II Receptors from Rat Brain , 1991, Journal of neurochemistry.

[42]  T. Schwartz,et al.  Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.

[43]  A. Spiegel,et al.  Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: effects on cell surface expression, dimerization and signal transduction , 1998, FEBS letters.

[44]  F. Ciruela,et al.  Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.

[45]  T. Schwartz,et al.  Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.

[46]  H. Mosberg,et al.  Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists. , 1990, European journal of pharmacology.

[47]  J. Wess,et al.  Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.

[48]  T. Hökfelt,et al.  Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. , 1981, Acta physiologica Scandinavica.

[49]  S. Nayfeh,et al.  Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line. , 1987, Endocrinology.

[50]  E. Kempner,et al.  Structure of the thyrotropin receptor and thyroid adenylate cyclase system as determined by target analysis. , 1984, Biochemistry.

[51]  J. Ellory,et al.  Molecular size of opiate (enkephalin) receptors in neuroblastoma-glioma hybrid cells as determined by radiation inactivation analysis. , 1983, Journal of Biological Chemistry.

[52]  P. Seeman,et al.  A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.

[53]  B. McEwen,et al.  Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  A. Maggi,et al.  beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. , 1980, Science.

[55]  P. Seeman,et al.  Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.

[56]  J. Holaday,et al.  beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. , 1988, The Journal of pharmacology and experimental therapeutics.

[57]  C Higgs,et al.  Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.

[58]  S. Paglin,et al.  Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. Cuatrecasas,et al.  Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking. , 1982, Biochemical and biophysical research communications.

[60]  J. Garnier,et al.  Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor. , 1990, Endocrinology.

[61]  L. Potter,et al.  Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.

[62]  M. Caron,et al.  Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.

[63]  J. Wess G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  A. Scheer,et al.  Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation. , 1998, Methods.

[65]  T. Rogers High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116,000 daltons. , 1984, The Journal of biological chemistry.

[66]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[67]  John R. Traynor,et al.  δ-opioid receptor subtypes and cross-talk with μ-receptors , 1993 .

[68]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  H. Lother,et al.  Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.

[71]  Michel Bouvier,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .

[72]  J. Venter,et al.  Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.

[73]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.

[74]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[75]  S. Coughlin Expanding horizons for receptors coupled to G proteins: diversity and disease. , 1994, Current opinion in cell biology.

[76]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[77]  T. Schwartz,et al.  Construction of a High Affinity Zinc Switch in the -Opioid Receptor (*) , 1996, The Journal of Biological Chemistry.

[78]  B. O'dowd,et al.  Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.

[79]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  E. Brown,et al.  Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[81]  J. Wess,et al.  Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.

[82]  J. Venter,et al.  Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. , 1985, Endocrinology.

[83]  C. Sander,et al.  Correlated mutations and residue contacts in proteins , 1994, Proteins.

[84]  C. Tanaka,et al.  Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c. , 1985, British journal of pharmacology.

[85]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[86]  H. Khorana,et al.  Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.

[87]  Q. Duh,et al.  Immunoprecipitation isolates multiple TSH receptor forms from human thyroid tissue. , 1995, Thyroid : official journal of the American Thyroid Association.

[88]  O. Gredal,et al.  Binding of [3H]SKF 38393 to Dopamine D‐l Receptors in Rat Striatum In Vitro; Estimation of Receptor Molecular Size by Radiation Inactivation , 1987, Journal of neurochemistry.

[89]  J. W. Wells,et al.  Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.

[90]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[91]  J. Morrison,et al.  Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[92]  L. Gama,et al.  Dimerization of the Calcium-sensing Receptor Occurs within the Extracellular Domain and Is Eliminated by Cys → Ser Mutations at Cys101 and Cys236 * , 1999, The Journal of Biological Chemistry.

[93]  S Avissar,et al.  Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[94]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[95]  T. Asano,et al.  Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells 1 , 1997, FEBS letters.

[96]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[97]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[98]  P. Seeman,et al.  Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.

[99]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[100]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[101]  D. Clapham,et al.  Specificity of receptor-G protein interactions: searching for the structure behind the signal. , 1993, Cellular signalling.

[102]  G. Köhr,et al.  Role of heteromer formation in GABAB receptor function. , 1999, Science.

[103]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[104]  H. Lother,et al.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.

[105]  Robert J. Lefkowitz,et al.  β-Adrenergic receptors: Evidence for negative cooperativity , 1975 .

[106]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[107]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.